Geographical Distribution of Factor V Laden in Different Regions of India
Keywords:
Abstract
Background: Factor V Leiden is the most common inherited form of thrombophilia with 3 to 8 percent European and American ancestry carrying one copy of the factor V Leiden mutation in each cell, and about 1 in 5,000 people have two copies of the mutation. The mutation is less common in Asian, Hispanic and African populations. Aim: This study was carried out to know the incidence of Factor V mutation in various regions of India. Methods: The presence of factor V mutation was determined by PCR- RFLP from patients suspected of thromboembolic etiology from medical, surgical, obstetrics and neonatology departments. Results: Analysis of 94 patients with coagulation disorders, factor V mutation was seen in 20 cases. Discussion: Although many reports from India indicate the absence of this mutation or the presence of homozygous mutation in a low level we report about 26 percent of the cases having the homozygous mutation which is the first for India.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
Craig Valle, M., Paul Isaac, Avi Baitner, David Steiger, Carriefang, Paul Cesare (2001) The relationship of the factor V Leiden mutation and the deletiondeletion polymorphism of the angiotensin converting enzyme to postoperative thromboemblic events following total joint arthroplasty. 2, 1.
Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de H, van PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. 369, 64-67.
N. Gupta, F. Khan, M. Tripathi, V. Singh, S. Tewari, V. Ramesh, N. Sinha, S. Agrawal (2003) Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India. 57(12), 535-542.
Herrmann FH, Koesling M, Schrŏder W, Altman R, Jiménez R, Lopaciuk S, Perez-Requejo JL, Singh JR (1997) Prevalence of factor V Leiden mutation in various populations. 14(4), 403-11.
Rohini Meenakshi-Sundaram, Sridhar, Jithendrian, Durai, Bharathi MJ Arunkumar, Sundar (2005) Case Report Recurrent Venous Thrombosis with Factor V Leiden Mutation. 53, 642-644.
D. Rees, M. Cox, J. Clegg (1995) World distribution of factor V Leiden. 346, 1133-1134.
Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB (1999) Born to clot: the European burden Br J Haematol. 105(2), 564-566.
8. http://www.genome.gov/15015167#Q5
Wan Zaidah, Abdullah, Subashini Kumaraguru, Selamah Ghazali, Mohd Narazah, Yusoff (2010) Factor V Leiden and Prothrombin G20210A Mutations Among Healthy Indians in Malaysia. 5(2), 284-287.
Abraham Koshy, Mary Jeyakumari (2006) Abraham Koshy. 140-142.
Frederick Anderson, Frederick Spencer (2003) Risk Factors for Venous Thromboembolism.
R. Wüthrich (2001) Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis. 409-414.
Published
2015-09-21
Issue
Section
License
Copyright (c) 2015 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.